Steven Cohen Terns Pharmaceuticals, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,690,376 shares of TERN stock, worth $19.7 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,690,376
Previous 2,690,376
-0.0%
Holding current value
$19.7 Million
Previous $18.3 Million
-0.0%
% of portfolio
0.05%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding TERN
# of Institutions
137Shares Held
64MCall Options Held
413KPut Options Held
106K-
Orbimed Advisors LLC San Diego, CA7.62MShares$55.8 Million1.25% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.18MShares$45.3 Million6.22% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.1MShares$44.7 Million1.36% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.95MShares$36.2 Million3.41% of portfolio
-
Black Rock Inc. New York, NY4.12MShares$30.2 Million0.0% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $275M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...